Elizabeth Etkin-Kramer MD

Gynecologist focused on disease prevention. Goal: identifying m/w w/ hereditary cancer genes. she/her. tweets my own. Oh and no filter.

[Ed Esplin, MD, PhD @EdEsplin]

@FunchainMD et al demonstrated that #pathogenic #germline #variants (PGVs)...contribute to many more #melanoma cases than previously thought (15.3%).

67% of PVs in genes previously considered unrelated to #melanoma

74% of PGV-positive #patients would not have met the “rule of 3” #germlinetesting criteria.

This speaks to a need to reconsider #genetictesting eligibility guidelines (@NCCN) & expand

c/w https://t.co/K6ru5opjd2 @FunchainMD et al. @Stanford @JAADjournals

#Universal #germline #genetictesting for all #patients w/ #melanoma

#access #reducedisparities #germline #genetictesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention

https://t.co/uXVwdDx1KZ #SooHyunKim et al. @JAMAOnc

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@EdEsplin Assuming all testing was done post panc cancer dx ....?

[Elizabeth Etkin-Kramer MD @EtkinKramer]

Join us this Wednesday, April 22 for a fascinating conversation about skin conditions tha affect our patients! Register now!

[The ObG Project @TheObGProject]

This month’s ObG Webinar: Go beyond the myths of adult acne and rosacea in women with this expert-led discussion. Designed to leave everyone listening in with at least one fresh takeaway

https://t.co/jsSw4g7Llt

#meded #ObGyn

[Elizabeth Etkin-Kramer MD @EtkinKramer]

Join us for a fascinating conversation about skin conditions that affect our patients!

[Dr. Sue Gross @DrSueGross]

You don’t want to miss an amazing talk by 2 top doctors in dermatology and Women’s Health/GYN
Topic: acne and rosacea -
These are common problems and often confused. Knowing the difference is key to management. looking forward to the learning!

@EtkinKramer

[~Jachnun Supremacist~ נפתלי בן מתתיהו @JachnunEmpire]

I just realized that Israelis have been reviewing bomb shelters and it’s amazing 😂

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@bariweiss @DouglasKMurray @CBSNews @TheFP @bariweiss video link?

[IJGC @IJGConline]

Hormone replacement therapy in #gynecologiccancer: oncologic safety and alternative therapies

💊 https://t.co/s7tbSk38SQ

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

[Elizabeth Etkin-Kramer MD @EtkinKramer]

https://t.co/hLVczxbJtW

[IJGC @IJGConline]

Oncologic outcomes of incidental #STIC & associated #HGSC in high-risk patients undergoing #risk-reducing surgery.

📌 Isolated STIC → 9% progression to primary peritoneal carcinoma
📌 Concomitant microscopic HGSC/STIC → 30% recurrence despite treatment
📊 10-yr OS: 87.5% (isolated) vs 67% (concurrent)
🔎 Pathologic excellence (SEE-FIM) + vigilant surveillance are critical. Timely RRS remains key.

🔗 https://t.co/aJ3mT1Pve7

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

#IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

[Contemporary OB/GYN® @ContempOBGYN]

A study found HPV vaccination was linked to lower odds of high-grade vulvar and vaginal lesions, with a 37-fold risk reduction in vaccinated vs unvaccinated women.
#HPVVaccine #CancerPrevention

Read more: https://t.co/7Lu5bZ0m7G

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@doclauravater 1000%.

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@fireflyann @allisonoconn No it's available to the public. Not just physicians. And it's free w registration.

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@fireflyann @allisonoconn It's free guidelines. You need to register and then look it up. https://t.co/Ixud20bOBO

[The ObG Project @TheObGProject]

An overview of the current USPSTF and @ASCO guidelines on pharmacologic interventions to reduce breast cancer risk, including risk assessment and medication options

https://t.co/dAPNYEoFnA

#gynoncology #ObGynTwitter

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@HHampel1 @EHTGtweets Impressive RR. Biallelic only ?

[Contemporary OB/GYN® @ContempOBGYN]

Experts warn routine hormone panel testing in menopause care is costly and clinically unnecessary. Despite costing hundreds, these tests don’t guide treatment and may mislead care decisions. #MenopauseCare #EvidenceBasedMedicine

Read more: https://t.co/QMw295JPMQ

[Inherited Cancer Registry (ICARE) @inheritedcancer]

Different #breastcancer genes🧬lead to different levels of #risk:
High risk genes (more than 4-fold risk) include #BRCA1, #BRCA2, #PALB2, #TP53, #PTEN, #CDH1
Less high risk genes (2-4 fold risk) include #CHEK2, #ATM, #BARD1, #RAD51C, #RAD51D

#InheritedCancer #Genetics #Education

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@azealiaslacewig https://t.co/elVV5ZyHxO

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@EylonALevy @havivrettiggur ideas?? Haviv does an incredible job integrating historical facts and current events.

[Elizabeth Etkin-Kramer MD @EtkinKramer]

@IanCarrollShow https://t.co/xp2LYismVG